Clinical trial
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for…
NCT00281827 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00281827 |
|---|---|
| Title | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer |
| Official title | Phase II Trial of Neoadjuvant Therapy With Carboplatin and Gemcitabine With Thalidomide in Patients With Stage II and IIIA Non-Small Cell Lung Cancer |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, gemcitabine hydrochloride, thalidomide, conventional surgery |
| Enrollment | 22 |
| Start date | May 1, 2002 |
| Primary completion | Mar 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 25, 2006 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: